<SEC-DOCUMENT>0001213900-17-013524-index.html : 20171221
<SEC-HEADER>0001213900-17-013524.hdr.sgml : 20171221
<ACCEPTANCE-DATETIME>20171221155826
ACCESSION NUMBER:		0001213900-17-013524
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171221
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171221
DATE AS OF CHANGE:		20171221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUCELL CORP /DE/
		CENTRAL INDEX KEY:			0000811641
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010382980
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12934
		FILM NUMBER:		171269462

	BUSINESS ADDRESS:	
		STREET 1:		56 EVERGREEN DR
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
		BUSINESS PHONE:		2078782770

	MAIL ADDRESS:	
		STREET 1:		56 EVERGREEN DRIVE
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k122117_immucellcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k122117_immucellcorp.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>f8k122117ex1-1_immucell.htm
<DESCRIPTION>UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC, DATED DECEMBER 19, 2017
<TEXT>
Document 2 - file: f8k122117ex1-1_immucell.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>f8k122117ex5-1_immucell.htm
<DESCRIPTION>OPINION OF PIERCE ATWOOD LLP
<TEXT>
Document 3 - file: f8k122117ex5-1_immucell.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>f8k122117ex99-1_immucell.htm
<DESCRIPTION>PRESS RELEASE OF IMMUCELL CORPORATION DATED DECEMBER 21, 2017.
<TEXT>
Document 4 - file: f8k122117ex99-1_immucell.htm

</DOCUMENT>
</SEC-DOCUMENT>